전립선염의 현재와 미래 = The Present and Future of Prostatitis

다국어 초록 (Multilingual Abstract)

Prostatitis is a common disease that is confusing and frustrating for urologists. Chronic prostatitis/chronic pelvic pain syndrome(CP/CPPS) is the most common form of prostatitis. The etiology of CP/CPPS is unknown, but possibilities include infectious, autoimmune, neurological, endocrine and psychological causes. Clinical evaluation can aid in diagnosis and follow-up of the patient's response to therapy. Treatment for CP/CPPS is empiric and limited by a lack of randomized, placebo- controlled clinical trials. Antimicrobials are commonly used to treat patients with prostatitis. Other commonly used drugs include α-adrenoceptor antagonists, anti-inflammatory drugs, tricyclic antidepressants, and anticholinergic agents. Also, minimally invasive procedures are considered in patients with CP/CPPS and It is possible to treat intractable patients with invasive treatment. Although much progress has been made in therapy, there is no distinct treatment for patients with CP/CPPS. If the concept of neurogenic inflammation with pain is solved, it is possible to treat patients with CP/CPPS at future. (Korean J Urol 2008;49:475-489)

참고문헌 (Reference)

1 조인래, "전립선염의 진단과 치료" 대한남성과학회 23 (23): 1-11, 2005

2 이창욱, "배뇨장애를 동반한 만성비세균성전립선염 환자의 요역동학 소견" 대한비뇨기과학회 47 (47): 268-271, 2006

3 한민철, "만성전립선염의 경과에 영향을 미치는 위험요인 분석" 대한비뇨기과학회 46 (46): 1040-1045, 2005

4 김태형, "만성전립선염에서 다중 중합효소연쇄반응을 이용한 잠복 미생물의 검출" 대한비뇨기과학회 48 (48): 304-309, 2007

5 이준호, "만성전립선염/만성골반통증후군 환자의 특징적인 증상" 대한비뇨기과학회 43 (43): 852-857, 2002

6 김용진, "만성 세균성전립선염-정낭염 환자에서 Fluoroquinolone 제제의 경구 및 국소주사요법의 효과" 대한비뇨기과학회 47 (47): 1185-1190, 2006

7 이건철, "만성 골반통증후군에서 체외자기장치료의 효과" 대한비뇨기과학회 44 (44): 693-696, 2003

8 양상국, "난치성 만성골반통증후군 환자에서 바이오피드백 및 기능성전기자극의 치료효과" 대한비뇨기과학회 44 (44): 1220-1224, 2003

9 조인래, "급성 세균성 전립선염 환자의 임상적 경과" 대한비뇨기과학회 46 (46): 1034-1039, 2005

10 Barbalias GA, "α-blockers for the treatment of chronic prostatitis in combination with antibiotics" 159 : 883-887, 1998

11 Zaichick VY, "Zinc concentration in human prostatic fluid: normal, chronic prostatitis, adenoma and cancer" 28 : 687-694, 1996

12 Goldstraw MA, "What is the role of inflammation in the pathogenesis of prostate cancer?" 99 : 966-968, 2007

13 Park SC, "What are the characteristic transrectal ultrasonographic findings in chronic prostatitis?" 39 : 530-536, 1998

14 Gul O, "Use of terazosine in patients with chronic pelvic pain syndrome and evaluation by prostatitis symptom score index" 32 : 433-436, 2001

15 Stamey TA, "Urinary tract infections in male in Pathogenesis and treatment of urinary tract infections. 1st ed." Williams & Wilkins 342-429, 1980

16 Nickel JC, "Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial" 171 : 1594-1597, 2004

17 Bozeman CB, "Treatment of chronic prostatitis lowers serum prostate specific antigen" 167 : 1723-1726, 2002

18 Leskinen MJ, "Transurethral needle ablation for the treatment of chronic pelvic pain syndrome(category III prostatitis): a randomized, sham- controlled study" 60 : 300-304, 2002

19 Bjerklund Johansen TE, "The role of antibiotics in the treatment of chronic prostatitis: a consensus statement" 34 : 457-466, 1998

20 Cho IR, "The prevalence of the symptoms of the prostate syndrome patients under 50" 39 : 751-756, 1998

21 Litwin MS, "The national institutes of health chronic prostatitis symptom index: development and validation of a new outcome measure" 162 : 369-375, 1999

22 Trevisani M, "The influence of alpha1-adrenoreceptors on neuropeptide release from primary sensory neurons of the lower urinary tract" 52 : 901-908, 2007

23 Jung YH, "The efficacy of terazosin in the management of chronic pelvic pain syndrome(CPPS): comparison between category IIIa and IIIb" 47 : 1191-1196, 2006

24 Cornel EB, "The effect of biofeedback physical therapy in men with chronic pelvic pain syndrome type III" 47 : 607-611, 2005

25 Patel U, "The diagnostic value of colour Doppler flow in the peripheral zone of the prostate, with histological correction" 74 : 590-595, 1994

26 Geppetti P, "The concept of neurogenic inflammation" 101(suppl 3) : 2-6, 2008

27 Kim YS, "Study of prostatic disease and symptom between special occupation groups(taxi driver, barber)" 39 : 1093-1097, 1998

28 Wenninger K, "Sickness impact of chronic nonbacterial prostatitis and its correlates" 155 : 965-968, 1996

29 Lee Seung Ju, "Screening for Chlamydia and Gonorrhea by Strand Displacement Amplification in Homeless Adolescents Attending Youth Shelters in Korea" 대한의학회 19 (19): 495-500, 2004

30 Yavascaoglu I, "Role of ejaculation in the treatment of chronic non-bacterial prostatitis" 6 : 130-134, 1999

31 Povlsen K, "Relationship of Ureaplasma urealyticum biovar 2 to nongonococcal urethritis" 21 : 97-101, 2002

32 Ku JH, "Relationship between chronic prostatitis and psychological problem" 42 : 521-527, 2001

33 Shoskes DA, "Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial" 54 : 960-963, 1999

34 Nickel JC, "Psychosocial variables affect the quality of life of men diagnosed with chronic prostatitis/ chronic pelvic pain syndrome" 101 : 59-64, 2008

35 Kaplan SA, "Pseudodyssynergia(contraction of the external sphincter during voiding) misdiagnosed as chronic nonbacterial prostatitis and the role of biofeedback as a therapeutic option" 157 : 2234-2237, 1997

36 Krieger JN, "Prostatitis: what is the role of infection" 19 : 475-479, 2002

37 Nickel JC, "Prostatitis: myths and realities" 51 : 362-366, 1998

38 Roberts RO, "Prostatitis as a risk factor for prostate cancer" 15 : 93-99, 2004

39 Woo YN, "Prostatitis" 35 : 575-585, 1994

40 Letran JL, "Prostate specific antigen and prostatitis. Textbook of prostatitis. 1st ed" Isis Medical Media 241-244, 1999

41 Cho IR, "Prostate blood flow characteristics in the chronic prostatitis/ pelvic pain syndrome" 163 : 1130-1133, 2000

42 Potts JM, "Prospective identification of NIH Category IV prostatitis in men with elevated prostate specific antigen" 164 : 1550-1553, 2000

43 Krieger JN, "Prokaryotic DNA sequences in patients with chronic idiopathic prostatitis" 34 : 3120-3128, 1996

44 Bartoletti R, "Prevalence, incidence estimation, risk factors and characterization of chronic prostatitis/chronic pelvic pain syndrome in urological hospital outpatients in Italy: results of a multicenter case-control observational study" 178 : 2411-2415, 2007

45 Yong DJ, "Prevalence of premature ejaculation in chronic pelvic pain syndrome" 25 : 21-25, 2007

46 Roberts RO, "Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted country study of urinary symptoms and health status among men" 51 : 578-584, 1998

47 Nickel JC, "Pre and post massage test(PPMT): a simple screen for prostatitis" 3 : 38-43, 1997

48 Zermann D, "Perisphincteric injection of botulinum toxin type A. A treatment option for patients with chronic prostatic pain?" 38 : 393-399, 2000

49 Nickel JC, "Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study" 173 : 1252-1255, 2005

50 이승언, "PSA 상승과 무증상 전립선염: 병리소견과의 연관성" 대한비뇨기과학회 47 (47): 31-36, 2006

51 Cho IR, "PSA and prostatitis in men under 45 years old" 39 : 633-637, 1998

52 Hellstrom WJ, "Neuromuscular dysfunction in nonbacterial prostatitis" 30 : 183-188, 1987

53 Schaeffer AJ, "National Institute of Diabetes and Digestive and Kidney Diseases of the US National Institutes of Health. NIDDK-sponsored chronic prostatitis collaborative research network(CPCRN) 5-year data and treatment guidelines for bacterial prostatitis" 24(suppl 1) : S49-S52, 2004

54 Krieger JN, "NIH consensus definition and classification of prostatitis" 282 : 236-237, 1999

55 Shoskes DA, "Muscle tenderness in men with chronic prostatitis/ chronic pelvic pain syndrome: the chronic prostatitis cohort study" 179 : 556-560, 2008

56 Lee SD, "Multicenter clinical outcome of gatifloxacin for chronic prostatitis(NIH category II or IIIa) in Korea" 2 : 53-60, 2007

57 Desireddi NV, "Monocyte chemoattractant protein-1 and macrophage inflammatory protein-1α as possible biomarkers for the chronic pelvic pain syndrome" 179 : 1857-1862, 2008

58 Pontari MA, "Mechanism in prostatitis/chronic pelvic pain syndrome" 172 : 839-845, 2004

59 Dimitrakov JD, "Management of chronic prostatitis/chronic pelvic pain syndrome: an evidence-based approach" 67 : 881-888, 2006

60 Roberts RO, "Low agreement between previous physician diagnosed prostatitis and national institutes of health chronic prostatitis symptom index pain measures" 171 : 279-283, 2004

61 Nickel JC, "Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial" 62 : 614-617, 2003

62 Cheah PY, "Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome" 64 : 881-886, 2004

63 Baert L, "In loco antibiotics in chronic bacterial prostatitis. Prostatitis. 1st ed." 191-196, 1994

64 Shoskes DA, "Impact of post-ejaculatory pain in men with category III chronic prostatitis/chronic pelvic pain syndrome" 172 : 542-547, 2004

65 Ward BB, "How many species of prokaryotes are there?" 99 : 10234-10236, 2002

66 Naber KG, "Guidelines on urinary and male genital tract infections. Guidelines. 1st ed" EAU 49-56, 2001

67 Persson BE, "Evidence for a mechanistic association between nonbacterial prostatitis and levels of urate and creatinine in expressed prostatic secretion" 155 : 958-960, 1996

68 Dennis LK, "Epidemiologic association between prostatitis and prostate cancer" 60 : 78-83, 2002

69 Kim TC, "Endoscopic evaluation ninty-one cases of chronic prostatitis" 3 : 51-58, 1962

70 Alexander RB, "Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic syndrome" 52 : 744-749, 1998

71 Fall M, "EAU guidelines on chronic pelvic pain" 46 : 681-689, 2004

72 Nickel JC, "Diagnosis and treatment of prostatitis in Canada" 52 : 797-802, 1998

73 McNaughton Collins M, "Diagnosis and treating chronic prostatitis: Do urologists use the four-glass test?" 55 : 403-407, 2000

74 Krieger JN, "Detecting urethral and prostatic inflammation in patients with chronic prostatitis" 55 : 186-192, 2000

75 Nickel JC, "Cytologic evaluation of urine is important in evaluation of chronic prostatitis" 60 : 225-227, 2002

76 Kastner C, "Cooled transurethral microwave thermotherapy for intractable chronic prostatitis - results of a pilot study after 1 year" 64 : 1149-1154, 2004

77 Shim BS, "Complementary and alternative therapy for chronic prostatitis/chronic pelvic pain syndrome" 2 : 143-150, 2007

78 Muller CH, "Comparison of microscopic methods for detecting inflammation in expressed prostatic secretions" 166 : 2518-2524, 2001

79 Ludwig M, "Comparison of expressed prostatic secretions with urine after prostatic massage - a means to diagnose chronic prostatitis/ inflammatory chronic pelvic pain syndrome" 55 : 175-177, 2000

80 Kim SW, "Clinical efficacy of extracorporeal magnetic innervation for chronic pelvic pain syndrome" 21 : 44-47, 2003

81 Naber KG, "Classification of fluoroquinolones" 10 : 255-257, 1998

82 Drach GW, "Classification of benign diseases associated with prostatic pain: prostatitis or prostatodynia?" 120 : 266-, 1978

83 Alexander RB, "Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial" 141 : 581-589, 2004

84 Cho IR, "Chronic prostatitis/chronic pelvic pain syndrome: guidelines for antibiotic therapy" 1 : 39-44, 2006

85 Pontari MA, "Chronic prostatitis/chronic pelvic pain syndrome" 35 : 81-89, 2008

86 Cho IR, "Chronic prostatitis and urethritis" 17 : 33-37, 1999

87 Naber KG, "Chronic prostatitis - an infectious disease?" 46 : 157-161, 2000

88 Krieger JN, "Chronic pelvic pains represent the most prominent urogenital symptoms of “chronic prostatitis”" 48 : 715-722, 1996

89 Hennenfent BR, "Changes in white blood cell counts in men undergoing thrice-weekly prostatic massage, microbial diagnosis and antimicrobial therapy for genitourinary complaints" 81 : 370-376, 1998

90 Cho IR, "Change of PSA and PSAD after antibiotic treatment in patients with prostatitis" 20 : 100-105, 2002

91 Berger RE, "Bladder petechiae after cystoscopy and hydrodistension in men daignosed with prostate pain" 159 : 83-85, 1998

92 Meares EM, "Bacteriologic localization patterns in bacterial prostatitis and urethritis" 5 : 492-518, 1968

93 Benway BM, "Bacterial prostatitis" 35 : 23-32, 2008

94 Berger RE, "Bacteria in the prostate tissue of men with idiopathic prostatic inflammation" 157 : 863-865, 1997

95 Krieger JN, "Bacteria in the chronic prostatitis- chronic pelvic pain syndrome: molecular approaches to critical research questions" 167 : 2574-2583, 2002

96 Jang JH, "Anaerobic bacterial isolation in patients with chronic prostatitis syndrome" 35 : 640-645, 1994

97 Persson BE, "Ameliorative effect of allopurinol on nonbacterial prostatitis: a parallel double-blind controlled study" 155 : 961-964, 1996

98 Mehik A, "Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo- controlled, pilot study" 62 : 425-429, 2003

99 Nickel JC, "A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome(category IIIA chronic nonbacterial prostatitis)" 93 : 991-995, 2004